| abstract |
The present invention provides rapid and complete absorption of a compound regardless of whether administered from cerebral infarction, sputum, traumatic injury of the spinal cord, intracranial injury, intracerebral hemorrhage, leprosy, Pneumocystis carini infection and any body tissue The purpose of this study is to show how to obtain N, N-diaminodiphenyl sulfonate in the form of a medicinal solution that is useful for obtaining the optimal drug for any symptom in need. As a representative example of its application, N, N diaminodiphenyl sulfonate was evaluated as a neuroprotector in acute cerebral infarction in mice. In this study, N, N diaminodiphenyl sulfonate was shown to significantly prevent brain damage without adverse effects on mice. In addition, medicinal solutions formulated in this form have also been shown to produce plasma condensation up to 30 minutes after administration in the oral route and immediately in the intravenous route. |